While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially ...

However, Kim said, the findings on optimal DAPT duration could potentially be applied regardless of the drug type. After the presentation, Anna E. Bortnick, MD, PhD, MSc, FACC, associate director ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

The evolution of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has been shaped by the continuous challenge of balancing ischaemic protection with bleeding risk. While ...

While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially among ...

and subsequent drug management was performed in 21.3% of the patients with abnormal responses. Appropriate management can influence clinical outcomes. Third, comparisons between the long- and ...

following DAPT. All patients had a prior myocardial infarction (MI), medication-treated diabetes or complex coronary artery lesions. Results showed that, at a median of 2.3 years follow-up, the ...